Clinical Trial: A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Chronic Obstructive Pulmonary Disease
Study Type: INTERVENTIONAL
Official Title: A Double-blinded Extension Study to Evaluate the Long-term Safety and Tolerability of Itepekimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Participated in Either EFC16750 or EF
Brief Summary:
This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments.The primary purpose of this study is to evaluate safety and tolerability of both itepekimab SC Q2W or itepekimab SC Q4W in participants with COPD having completed the treatment period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond…
Read more